Literature DB >> 9210907

Apoptosis and secondary necrosis of lymphocytes in culture.

I Vermes1, C Haanen, D J Richel, M R Schaafsma, E Kalsbeek-Batenburg, C P Reutelingsperger.   

Abstract

It has been reported that cultured peripheral B lymphocytes of chronic lymphocytic leukemia (B-CLL) patients show a high degree of apoptosis (programmed cell death). Till now, no data exist about the occurrence of in vitro apoptosis of normal B and T cells. We measured the amount of apoptosis and secondary necrosis (type 2 necrosis) in B-CLL lymphocytes and in normal peripheral B and T lymphocytes in culture. Observations were made on B-CLL lymphocytes and on normal B and T cells purified by immunomagnetic cell sorting. Apoptosis and secondary necrosis were measured using a recently described sensitive flow-cytometric assay, probing simultaneously for cell surface exposure of phosphatidylserine with the use of FITC-labeled annexin-V and for cell membrane integrity as demonstrated by the exclusion of propidium iodide. The degree of in vitro apoptosis and secondary necrosis of normal B cells appears to be higher than that of normal T cells, and even higher than that of B-CLL cells. The results indicate that cultured mature circulating normal B lymphocytes exhibit a higher cell death rate than normal T cells and B-CLL lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210907     DOI: 10.1159/000203546

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  9 in total

Review 1.  The role of defective clearance of apoptotic cells in systemic autoimmunity.

Authors:  Luis E Muñoz; Kirsten Lauber; Martin Schiller; Angelo A Manfredi; Martin Herrmann
Journal:  Nat Rev Rheumatol       Date:  2010-05       Impact factor: 20.543

2.  Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Y Furukawa; C R Bangham; G P Taylor; J N Weber; M Osame
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

3.  Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937.

Authors:  Nathalie Perek; Odile Sabido; Nathalie Le Jeune; Nathalie Prevot; Jean-Michel Vergnon; Anthony Clotagatide; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-13       Impact factor: 9.236

4.  [The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE].

Authors:  L E Muñoz; K Lauber; M Schiller; A A Manfredi; G Schett; R E Voll; M Herrmann
Journal:  Z Rheumatol       Date:  2010-03       Impact factor: 1.372

5.  High ACSL5 transcript levels associate with systemic lupus erythematosus and apoptosis in Jurkat T lymphocytes and peripheral blood cells.

Authors:  Antonio Catalá-Rabasa; Dorothy Ndagire; Jose Mario Sabio; Maria Fedetz; Fuencisla Matesanz; Antonio Alcina
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

6.  Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?

Authors:  J Ostrowski; T Wocial; H Skurzak; W Bartnik
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

Review 7.  Inflammatory etiopathogenesis of systemic lupus erythematosus: an update.

Authors:  Malgorzata J Podolska; Mona Hc Biermann; Christian Maueröder; Jonas Hahn; Martin Herrmann
Journal:  J Inflamm Res       Date:  2015-08-20

8.  KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri.

Authors:  Lisa Kater; Benjamin Kater; Michael A Jakupec; Bernhard K Keppler; Aram Prokop
Journal:  J Biol Inorg Chem       Date:  2021-10-06       Impact factor: 3.358

9.  Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells.

Authors:  C Pepper; H Lowe; C Fegan; C Thurieau; D E Thurston; J A Hartley; P Delavault
Journal:  Br J Cancer       Date:  2007-06-19       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.